Is This Biotech Stock Immune to Volatility?
Biotech stock DCPH is down 80% since the pandemic, but it’s UP so far in 2022. Will the stock land on Chad’s Bank It list today?
Posted by Chad Shoop | Jun 16, 2022 | Investing, Quick Takes, Trading Strategies, True Options Masters
Biotech stock DCPH is down 80% since the pandemic, but it’s UP so far in 2022. Will the stock land on Chad’s Bank It list today?
Posted by Jay Goldberg | Mar 31, 2022 | Investment Opportunities, Stocks, Winning Investor Daily
There’s one industry with a proven track record of pumping out double- and triple-digit winners.
Posted by Andrew Prince | Mar 30, 2022 | Investment Opportunities, Stocks, Winning Investor Daily
I find one type of stock equal parts frustrating and fascinating — biotechs.
Posted by Steve Fernandez | Mar 21, 2022 | Investment Opportunities, Stocks, Winning Investor Daily
A big move is coming for biotech and pharmaceutical stocks.
Posted by Steve Fernandez | Mar 14, 2022 | Investment Opportunities, Technology, Winning Investor Daily
Politicians aren’t telling you the truth about inflation. Nor will they tell you the cure will come from a lab.
Subscribe to our Banyan Edge newsletter to get financial insights and tips from our top investment experts. Start investing with an edge today!
Editor of Alpha Investor
Director of VIP Services
CEO of Banyan Hill
Research Analyst
Chief Investment Strategist of Money & Markets
Director of Investment Research
Editor of Precision Profits and Apex Alert
Editor of Strategic Fortunes and three elite services
“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”
- David G. (Member since 2018)
“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”
- Larry K.
"You have done once again!! You are reminding me of the GREAT Joe DiMaggio with your consistent hitting!! You knocked this one out of the park!"
- Keith S.